Advertisement

Application of PET and PET-CT in Cancer of the Gastrointestinal System

  • B. R. Mittal
  • Rahul Parghane
  • J. Mohan Roop
Chapter

Abstract

Esophageal and gastric cancers are highly aggressive malignancies with poor prognosis. Surgical resection is the primary curative treatment for early esophageal and gastric cancers. Multimodality treatment involving preoperative chemotherapy with or without radiation followed by surgical resection in suitable patients is increasingly becoming popular in patients who have locally advanced cancers.

Keywords

Gastric Cancer Esophageal Cancer Neuroendocrine Tumor Signet Ring Cell Carcinoma Islet Cell Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

For Further Reading

  1. 1.
    Bang S, Chung HW, Park SW, et al. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. J Clin Gastroenterol. 2006;40:923–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer. 2005;103:2383–90.PubMedCrossRefGoogle Scholar
  3. 3.
    Dierckx R, Maes A, Peeters M, Van De Wiele C. FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases. Q J Nucl Med Mol Imaging. 2009;53:336–42.PubMedGoogle Scholar
  4. 4.
    Gayed I, Vu T, Iyer R, et al. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med. 2004;45:17–21.PubMedGoogle Scholar
  5. 5.
    Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol. 2008;14:3773–80.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic or recurrent gastric cancer. J Nucl Med. 2003;44:690–9.PubMedGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Department of Nuclear Medicine and PETPostgraduate Institute of Medical Sciences and ResearchChandigarhIndia

Personalised recommendations